Full Text View
Tabular View
No Study Results Posted
Related Studies
A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and Symbicort® pMDI 2 x 80/4.5 μg Bid With Formoterol Turbuhaler®, Budesonide pMDI, the Combination of Formoterol Turbuhaler® and Budesonide pMDI, and Placebo in COPD Patients
This study has been completed.
First Received: September 13, 2005   Last Updated: March 26, 2009   History of Changes
Sponsor: AstraZeneca
Information provided by: AstraZeneca
ClinicalTrials.gov Identifier: NCT00206154
  Purpose

The purpose of this study is to compare a combination asthma drug (Symbicort) with its two components, budesonide and formoterol, taken individually or in combination, and with placebo in the long-term maintenance treatment of patients with chronic obstructive pulmonary disease (COPD)


Condition Intervention Phase
Chronic Obstructive Pulmonary Disease
Drug: Budesonide/formoterol pMDI
Drug: Budesonide pMDI
Drug: Formoterol Turbuhaler
Phase III

Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Official Title: A 6-Month Double-Blind, Double-Dummy, Randomized, Parallel Group, Multicenter Efficacy & Safety Study of SYMBICORT® pMDI 2 x 160/4.5 µg & 80/4.5 µg Bid Compared to Formoterol TBH, Budesonide pMDI (& the Combination) & Placebo in COPD Patients

Resource links provided by NLM:


Further study details as provided by AstraZeneca:

Primary Outcome Measures:
  • Pre-dose and 1-hour post-dose FEV1 over the 6 months treatment period

Secondary Outcome Measures:
  • Patient-reported outcome variables regarding disease status (incl. PEF), collected via questionnaires and diaries
  • Health care utilization
  • Pharmacokinetics (subgroup)
  • Safety variables, including adverse events, vital signs, ECG, physical examination, hematology, and clinical chemistry.
  • - all variables assessed over the 6 months treatment period

Estimated Enrollment: 1500
Study Start Date: April 2005
Study Completion Date: December 2006
  Eligibility

Ages Eligible for Study:   40 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • A clinical diagnosis of COPD with symptoms for more than 2 years
  • Smoking history of 10 or more pack years
  • A history of at least one COPD exacerbation requiring a course of oral steroids and/or antibiotics within 1-12 months before first visit.

Exclusion Criteria:

  • A history of asthma
  • Patients taking oral steroids.
  • Any significant disease or disorder that may jeopardize the safety of the patient
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00206154

  Hide Study Locations
Locations
United States, Alabama
Research Site
Birmingham, Alabama, United States
Research Site
Jasper, Alabama, United States
Research Site
Mobile, Alabama, United States
United States, Arizona
Research Site
Phoenix, Arizona, United States
Research Site
Mesa, Arizona, United States
Research Site
Glendale, Arizona, United States
United States, Arkansas
Research Site
Fort Smith, Arkansas, United States
Research Site
Little Rock, Arkansas, United States
Research Site
Searcy, Arkansas, United States
United States, California
Research Site
Anaheim, California, United States
Research Site
Long Beach, California, United States
Research Site
Irvine, California, United States
Research Site
Fullerton, California, United States
Research Site
Los Angeles, California, United States
Research Site
Mission Viejo, California, United States
Research Site
Orange, California, United States
Research Site
Rancho Cordova, California, United States
Research Site
San Jose, California, United States
Research Site
San Diego, California, United States
Research Site
Riverside, California, United States
Research Site
Sepulveda, California, United States
Research Site
Signal Hill, California, United States
Research Site
Stockton, California, United States
Research Site
Torrance, California, United States
Research Site
Walnut Creek, California, United States
United States, Colorado
Research Site
Colorado Springs, Colorado, United States
Research Site
Denver, Colorado, United States
Research Site
Wheat Ridge, Colorado, United States
United States, Connecticut
Research Site
Bristol, Connecticut, United States
Research Site
Waterbury, Connecticut, United States
United States, Florida
Research Site
Bay Pines, Florida, United States
Research Site
Brandon, Florida, United States
Research Site
Clearwater, Florida, United States
Research Site
Panama City, Florida, United States
Research Site
Largo, Florida, United States
Research Site
Miami Beach, Florida, United States
Research Site
Naples, Florida, United States
Research Site
Ocala, Florida, United States
Research Site
Ormond Beach, Florida, United States
Research Site
DeLand, Florida, United States
Research Site
Pembroke Pines, Florida, United States
Research Site
Port Orange, Florida, United States
Research Site
Sarasota, Florida, United States
United States, Georgia
Research Site
Blairsville, Georgia, United States
Research Site
Rome, Georgia, United States
Research Site
Marietta, Georgia, United States
Research Site
Blue Ridge, Georgia, United States
United States, Idaho
Research Site
Coeur d'Alene, Idaho, United States
United States, Illinois
Research Site
Bloomington, Illinois, United States
Research Site
Chicago, Illinois, United States
Research Site
Hines, Illinois, United States
Research Site
Normal, Illinois, United States
Research Site
North Chicago, Illinois, United States
Research Site
O'Fallon, Illinois, United States
United States, Indiana
Research Site
Evansville, Indiana, United States
Research Site
South Bend, Indiana, United States
United States, Iowa
Research Site
Iowa City, Iowa, United States
Research Site
Waterloo, Iowa, United States
United States, Kansas
Research Site
Mission, Kansas, United States
Research Site
Wichita, Kansas, United States
United States, Kentucky
Research Site
Lebanon, Kentucky, United States
Research Site
Louisville, Kentucky, United States
Research Site
Madisonville, Kentucky, United States
Research Site
Paducah, Kentucky, United States
United States, Louisiana
Research Site
Marrero, Louisiana, United States
Research Site
Lafayette, Louisiana, United States
Research Site
Baton Rouge, Louisiana, United States
Research Site
New Orleans, Louisiana, United States
Research Site
Shreveport, Louisiana, United States
Research Site
Sunset, Louisiana, United States
United States, Maine
Research Site
Auburn, Maine, United States
Research Site
Bangor, Maine, United States
United States, Maryland
Research Site
Baltimore, Maryland, United States
United States, Massachusetts
Research Site
Taunton, Massachusetts, United States
United States, Minnesota
Research Site
Minneapolis, Minnesota, United States
Research Site
Plymouth, Minnesota, United States
Research Site
St Paul, Minnesota, United States
United States, Missouri
Research Site
Chesterfield, Missouri, United States
Research Site
St. Charles, Missouri, United States
Research Site
St. Louis, Missouri, United States
United States, Montana
Research Site
Butte, Montana, United States
Research Site
Missoula, Montana, United States
United States, Nebraska
Research Site
Omaha, Nebraska, United States
Research Site
Papillion, Nebraska, United States
Research Site
Scottsbluff, Nebraska, United States
United States, Nevada
Research Site
Las Vegas, Nevada, United States
Research Site
Pahrump, Nevada, United States
Research Site
Reno, Nevada, United States
United States, New Jersey
Research Site
Cherry Hill, New Jersey, United States
Research Site
Skillman, New Jersey, United States
Research Site
Springfield, New Jersey, United States
United States, New Mexico
Research Site
Albuquerque, New Mexico, United States
United States, New York
Research Site
Bay Shore, New York, United States
Research Site
Buffalo, New York, United States
Research Site
Larchmont, New York, United States
Research Site
Mineola, New York, United States
Research Site
New York, New York, United States
Research Site
Rochester, New York, United States
United States, North Carolina
Research Site
Winston-Salem, North Carolina, United States
Research Site
Raleigh, North Carolina, United States
Research Site
Chapel Hill, North Carolina, United States
United States, North Dakota
Research Site
Bismarck, North Dakota, United States
United States, Ohio
Research Site
Akron, Ohio, United States
Research Site
Cincinnati, Ohio, United States
Research Site
Cleveland, Ohio, United States
Research Site
Mogadore, Ohio, United States
Research Site
Sylvania, Ohio, United States
Research Site
Zanesville, Ohio, United States
United States, Oklahoma
Research Site
Oklahoma City, Oklahoma, United States
United States, Oregon
Research Site
Eugene, Oregon, United States
Research Site
Medford, Oregon, United States
Research Site
Portland, Oregon, United States
United States, Pennsylvania
Research Site
Easton, Pennsylvania, United States
Research Site
Erie, Pennsylvania, United States
Research Site
Hershey, Pennsylvania, United States
Research Site
Philadelphia, Pennsylvania, United States
Research Site
Pittsburgh, Pennsylvania, United States
Research Site
Ridley Park, Pennsylvania, United States
Research Site
Swarthmore, Pennsylvania, United States
Research Site
West Chester, Pennsylvania, United States
United States, Rhode Island
Research Site
East Providence, Rhode Island, United States
United States, South Carolina
Research Site
Charleston, South Carolina, United States
Research Site
Simpsonville, South Carolina, United States
Research Site
Spartanburg, South Carolina, United States
United States, Texas
Research Site
Austin, Texas, United States
Research Site
El Paso, Texas, United States
Research Site
Dallas, Texas, United States
Research Site
Barker, Texas, United States
Research Site
Fort Worth, Texas, United States
Research Site
Houston, Texas, United States
Research Site
Killeen, Texas, United States
Research Site
New Braunfels, Texas, United States
Research Site
San Antonio, Texas, United States
United States, Virginia
Research Site
Abingdon, Virginia, United States
Research Site
Charlottesville, Virginia, United States
Research Site
Richmond, Virginia, United States
Research Site
Salem, Virginia, United States
Research Site
Virginia Beach, Virginia, United States
United States, Washington
Research Site
Bellingham, Washington, United States
Research Site
Seattle, Washington, United States
Research Site
Spokane, Washington, United States
Research Site
Tacoma, Washington, United States
United States, Wisconsin
Research Site
La Crosse, Wisconsin, United States
Czech Republic
Research Site
Beroun, Czech Republic
Research Site
Cvikov, Czech Republic
Research Site
Jarom¿¿, Czech Republic
Research Site
Karlovy Vary, Czech Republic
Research Site
Kladno, Czech Republic
Research Site
Strakonice, Czech Republic
Research Site
Liberec, Czech Republic
Research Site
Lovosice, Czech Republic
Research Site
Neratovice, Czech Republic
Research Site
Olomouc, Czech Republic
Research Site
Ostrava 1, Czech Republic
Research Site
Plzen, Czech Republic
Research Site
Praha 1, Czech Republic
Research Site
Praha 2, Czech Republic
Research Site
Praha 5, Czech Republic
Research Site
Praha 8, Czech Republic
Research Site
Rokycany, Czech Republic
Research Site
Kutná Hora, Czech Republic
Research Site
Ústí nad Labem, Czech Republic
Research Site
Znojmo, Czech Republic
Czech Republic, CZ
Research Site
Praha 8, CZ, Czech Republic
Research Site
Ústí nad Labem, CZ, Czech Republic
Netherlands
Research Site
ALMELO, Netherlands
Research Site
ARNHEM, Netherlands
Research Site
BREDA, Netherlands
Research Site
TERNEUZEN, Netherlands
Research Site
EINDHOVEN, Netherlands
Research Site
GRONINGEN, Netherlands
Research Site
HARDERWIJK, Netherlands
Research Site
HEERLEN, Netherlands
Research Site
NIEUWEGEIN, Netherlands
Research Site
DEN HAAG, Netherlands
Research Site
TILBURG, Netherlands
Research Site
UTRECHT, Netherlands
Poland
Research Site
Bia¿ystok, Poland
Research Site
Bydgoszcz, Poland
Research Site
Bystra ¿l¿ska, Poland
Research Site
Ch¿ciny, Poland
Research Site
Chrzanów, Poland
Research Site
Kraków, Poland
Research Site
Gidle, Poland
Research Site
Gorzów Wlkp, Poland
Research Site
I¿awa, Poland
Research Site
Karpacz, Poland
Research Site
Cz¿stochowa, Poland
Research Site
Lublin, Poland
Research Site
¿ód¿, Poland
Research Site
¿om¿a, Poland
Research Site
Ostrów Wielkopolski, Poland
Research Site
Otowck, Poland
Research Site
Pozna¿, Poland
Research Site
Proszowice, Poland
Research Site
Warszawa, Poland
Research Site
Siedlce, Poland
Research Site
Sopot, Poland
Research Site
Szczecin, Poland
Research Site
Tarnów, Poland
Research Site
Turek, Poland
Research Site
Radom, Poland
Research Site
Wo¿omin, Poland
Research Site
Zabrze, Poland
Research Site
Zawadzkie, Poland
South Africa
Research Site
Cape Town, South Africa
Research Site
Umkomaas, South Africa
Research Site
Lyttelton Manor, South Africa
Research Site
Durban, South Africa
Research Site
Port Elizabeth, South Africa
South Africa, Cape Province
Research Site
Parow, Cape Province, South Africa
South Africa, Gauteng
Research Site
Lenasia, Gauteng, South Africa
Research Site
Pretoria, Gauteng, South Africa
Research Site
Witbank, Gauteng, South Africa
South Africa, Western Cape
Research Site
Cape Town, Western Cape, South Africa
Sponsors and Collaborators
AstraZeneca
Investigators
Study Director: AstraZeneca Symbicort Medical Science Director, MD AstraZeneca
  More Information

No publications provided

Study ID Numbers: D5899C00002, EurodraCT No: 2004-001183-41
Study First Received: September 13, 2005
Last Updated: March 26, 2009
ClinicalTrials.gov Identifier: NCT00206154     History of Changes
Health Authority: United States: Food and Drug Administration

Additional relevant MeSH terms:
Anti-Inflammatory Agents
Respiratory System Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Adrenergic Agents
Adrenergic beta-Agonists
Symbicort
Physiological Effects of Drugs
Hormones, Hormone Substitutes, and Hormone Antagonists
Budesonide
Anti-Asthmatic Agents
Hormones
Glucocorticoids
Adrenergic Agonists
Pharmacologic Actions
Lung Diseases, Obstructive
Respiratory Tract Diseases
Autonomic Agents
Therapeutic Uses
Lung Diseases
Formoterol
Peripheral Nervous System Agents
Bronchodilator Agents
Pulmonary Disease, Chronic Obstructive

ClinicalTrials.gov processed this record on November 27, 2009